Literature DB >> 24825548

Cardiomyocytes mediate anti-angiogenesis in type 2 diabetic rats through the exosomal transfer of miR-320 into endothelial cells.

Xiaohong Wang1, Wei Huang2, Guansheng Liu3, Wenfeng Cai2, Ronald W Millard3, Yigang Wang2, Jiang Chang4, Tianqing Peng5, Guo-Chang Fan6.   

Abstract

Exosomes, nano-vesicles naturally released from living cells, have been well recognized to play critical roles in mediating cell-to-cell communication. Given that diabetic hearts exhibit insufficient angiogenesis, it is significant to test whether diabetic cardiomyocyte-derived exosomes possess any capacity in regulating angiogenesis. In this study, we first observed that both proliferation and migration of mouse cardiac endothelial cells (MCECs) were inhibited when co-cultured with cardiomyocytes isolated from adult Goto-Kakizaki (GK) rats, a commonly used animal model of type 2 diabetes. However, GK-myocyte-mediated anti-angiogenic effects were negated upon addition of GW4869, an inhibitor of exosome formation/release, into the co-cultures. Next, exosomes were purified from the myocyte culture supernatants by differential centrifugation. While exosomes derived from GK myocytes (GK-exosomes) displayed similar size and molecular markers (CD63 and CD81) to those originated from the control Wistar rat myocytes (WT-exosomes), their regulatory role in angiogenesis is opposite. We observed that the MCEC proliferation, migration and tube-like formation were inhibited by GK-exosomes, but were promoted by WT-exosomes. Mechanistically, we found that GK-exosomes encapsulated higher levels of miR-320 and lower levels of miR-126 compared to WT-exosomes. Furthermore, GK-exosomes were effectively taken up by MCECs and delivered miR-320. In addition, transportation of miR-320 from myocytes to MCECs could be blocked by GW4869. Importantly, the exosomal miR-320 functionally down-regulated its target genes (IGF-1, Hsp20 and Ets2) in recipient MCECs, and overexpression of miR-320 inhibited MCEC migration and tube formation. GK exosome-mediated inhibitory effects on angiogenesis were removed by knockdown of miR-320. Together, these data indicate that cardiomyocytes exert an anti-angiogenic function in type 2 diabetic rats through exosomal transfer of miR-320 into endothelial cells. Thus, our study provides a novel mechanism underlying diabetes mellitus-induced myocardial vascular deficiency which may be caused by secretion of anti-angiogenic exosomes from cardiomyocyes.
Copyright © 2014 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Cardiomyocytes; Exosomes; Myocardial angiogenesis; Type 2 diabetes; miR-320

Mesh:

Substances:

Year:  2014        PMID: 24825548      PMCID: PMC4120246          DOI: 10.1016/j.yjmcc.2014.05.001

Source DB:  PubMed          Journal:  J Mol Cell Cardiol        ISSN: 0022-2828            Impact factor:   5.000


  29 in total

1.  Angiogenesis, arteriogenesis, and diabetes: paradigm reassessed?

Authors:  Michael Simons
Journal:  J Am Coll Cardiol       Date:  2005-09-06       Impact factor: 24.094

Review 2.  Endothelial-cardiomyocyte interactions in cardiac development and repair.

Authors:  Patrick C H Hsieh; Michael E Davis; Laura K Lisowski; Richard T Lee
Journal:  Annu Rev Physiol       Date:  2006       Impact factor: 19.318

3.  AngiomiR-126 expression and secretion from circulating CD34(+) and CD14(+) PBMCs: role for proangiogenic effects and alterations in type 2 diabetics.

Authors:  Pavani Mocharla; Sylvie Briand; Giovanna Giannotti; Carola Dörries; Philipp Jakob; Francesco Paneni; Thomas Lüscher; Ulf Landmesser
Journal:  Blood       Date:  2012-11-08       Impact factor: 22.113

Review 4.  The GK rat: a prototype for the study of non-overweight type 2 diabetes.

Authors:  Bernard Portha; Marie-Hélène Giroix; Cecile Tourrel-Cuzin; Hervé Le-Stunff; Jamileh Movassat
Journal:  Methods Mol Biol       Date:  2012

5.  Secreted monocytic miR-150 enhances targeted endothelial cell migration.

Authors:  Yujing Zhang; Danqing Liu; Xi Chen; Jing Li; Limin Li; Zhen Bian; Fei Sun; Jiuwei Lu; Yuan Yin; Xing Cai; Qi Sun; Kehui Wang; Yi Ba; Qiang Wang; Dongjin Wang; Junwei Yang; Pingsheng Liu; Tao Xu; Qiao Yan; Junfeng Zhang; Ke Zen; Chen-Yu Zhang
Journal:  Mol Cell       Date:  2010-07-09       Impact factor: 17.970

6.  Rescue of diabetes-related impairment of angiogenesis by intramuscular gene therapy with adeno-VEGF.

Authors:  A Rivard; M Silver; D Chen; M Kearney; M Magner; B Annex; K Peters; J M Isner
Journal:  Am J Pathol       Date:  1999-02       Impact factor: 4.307

7.  Recovery from hind limb ischemia is less effective in type 2 than in type 1 diabetic mice: roles of endothelial nitric oxide synthase and endothelial progenitor cells.

Authors:  Jinglian Yan; Guodong Tie; Brian Park; Yagai Yan; Philip T Nowicki; Louis M Messina
Journal:  J Vasc Surg       Date:  2009-10-17       Impact factor: 4.268

Review 8.  An update on the treatment of type 1 and type 2 diabetes mellitus: focus on insulin detemir, a long-acting human insulin analog.

Authors:  Katarina Raslova
Journal:  Vasc Health Risk Manag       Date:  2010-06-01

Review 9.  Extracellular vesicles: exosomes, microvesicles, and friends.

Authors:  Graça Raposo; Willem Stoorvogel
Journal:  J Cell Biol       Date:  2013-02-18       Impact factor: 10.539

Review 10.  Exosome function: from tumor immunology to pathogen biology.

Authors:  Jeffrey S Schorey; Sanchita Bhatnagar
Journal:  Traffic       Date:  2008-03-06       Impact factor: 6.215

View more
  172 in total

1.  Noncoding RNAs regulating cardiac muscle mass.

Authors:  Glenn D Wadley; Séverine Lamon; Sarah E Alexander; Julie R McMullen; Bianca C Bernardo
Journal:  J Appl Physiol (1985)       Date:  2018-12-20

Review 2.  Circulating microRNAs in cardiovascular diseases: from biomarkers to therapeutic targets.

Authors:  Feng Wang; Chen Chen; Daowen Wang
Journal:  Front Med       Date:  2014-12-01       Impact factor: 4.592

Review 3.  Circulating microRNAs and diabetes: potential applications in medical practice.

Authors:  Juliette Raffort; Charlotte Hinault; Olivier Dumortier; Emmanuel Van Obberghen
Journal:  Diabetologia       Date:  2015-07-09       Impact factor: 10.122

Review 4.  Mesenchymal Stem Cell (MSC)-Derived Extracellular Vesicles: Potential Therapeutics as MSC Trophic Mediators in Regenerative Medicine.

Authors:  Qi-Ling Yuan; Yin-Gang Zhang; Qian Chen
Journal:  Anat Rec (Hoboken)       Date:  2019-06-17       Impact factor: 2.064

5.  Emerging Roles of Extracellular Vesicles Derived Non-Coding RNAs in the Cardiovascular System.

Authors:  Ramasamy Subbiah; Divya Sridharan; Karthika Duairaj; K Shanmugha Rajan; Mahmood Khan; Venkata Naga Srikanth Garikipati
Journal:  Subcell Biochem       Date:  2021

Review 6.  Extracellular vesicles in cardiovascular diseases.

Authors:  Shihui Fu; Yujie Zhang; Yulong Li; Leiming Luo; Yali Zhao; Yao Yao
Journal:  Cell Death Discov       Date:  2020-07-30

7.  Effect of IL-1β, TNF-α and IGF-1 on trans-endothelial passage of synthetic vectors through an in vitro vascular endothelial barrier of striated muscle.

Authors:  J P Gomez; C Gonçalves; C Pichon; P Midoux
Journal:  Gene Ther       Date:  2017-05-15       Impact factor: 5.250

Review 8.  MicroRNAs as paracrine signaling mediators in cancers and metabolic diseases.

Authors:  Akiko Matsuda; Irene K Yan; Catherine Foye; Mansi Parasramka; Tushar Patel
Journal:  Best Pract Res Clin Endocrinol Metab       Date:  2016-08-01       Impact factor: 4.690

9.  Targeting miRNA for Therapy of Juvenile and Adult Diabetic Cardiomyopathy.

Authors:  Shyam Sundar Nandi; Paras Kumar Mishra
Journal:  Adv Exp Med Biol       Date:  2018       Impact factor: 2.622

Review 10.  Heart failure and diabetes: role of ATM.

Authors:  Mary C Wingard; Chad R Frasier; Mahipal Singh; Krishna Singh
Journal:  Curr Opin Pharmacol       Date:  2020-08-01       Impact factor: 5.547

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.